Related Experiment Video
Updated: Jan 27, 2026

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans
Published on: August 28, 2018
Serum Calcification Propensity and Coronary Artery Calcification Among Patients With CKD: The CRIC (Chronic Renal
Joshua D Bundy1, Xuan Cai2, Julia J Scialla3
1Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL; Center for Translational Metabolism and Health, Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL.
Insights
Higher serum calcification propensity, measured by T50, is linked to more severe coronary artery calcification (CAC) and its progression in chronic kidney disease (CKD) patients. This finding aids in understanding cardiovascular risks in CKD.
Area of Science:
- Nephrology
- Cardiology
- Biochemistry
Background:
- Coronary artery calcification (CAC) is common in chronic kidney disease (CKD) and predicts cardiovascular events.
- A novel serum measure of calcification propensity may offer insights into CAC development in CKD.
Purpose of the Study:
- To investigate the association between serum calcification propensity (T50) and CAC in patients with CKD stages 2-4.
- To determine if T50 predicts CAC severity, incidence, and progression.
Main Methods:
- Prospective cohort study of 1,274 participants from the Chronic Renal Insufficiency Cohort (CRIC) Study.
- Serum calcification propensity quantified as transformation time (T50).
- Multivariable-adjusted generalized linear models used to analyze CAC prevalence, severity, incidence, and progression.
Main Results:
- Higher calcification propensity (lower T50) was associated with greater CAC severity (21% increase per 1-SD lower T50).
- Higher calcification propensity was associated with a 28% higher risk of CAC progression over 3 years.
- T50 was not associated with CAC prevalence or incidence.
Conclusions:
- Serum calcification propensity is associated with CAC severity and progression in CKD patients.
- T50 may serve as a biomarker for cardiovascular risk in CKD.
- Further research is needed to confirm these findings and explore clinical utility.
Rationale & Objective:
Coronary artery calcification (CAC) is prevalent among patients with chronic kidney disease (CKD) and increases risks for cardiovascular disease events and mortality. We hypothesized that a novel serum measure of calcification propensity is associated with CAC among patients with CKD stages 2 to 4.
Study Design:
Prospective cohort study.
Setting & Participants:
Participants from the Chronic Renal Insufficiency Cohort (CRIC) Study with baseline (n=1,274) and follow-up (n=780) CAC measurements.
Predictors:
Calcification propensity, quantified as transformation time (T50) from primary to secondary calciprotein particles, with lower T50 corresponding to higher calcification propensity. Covariates included age, sex, race/ethnicity, clinical site, estimated glomerular filtration rate, proteinuria, diabetes, systolic blood pressure, number of antihypertensive medications, current smoking, history of cardiovascular disease, total cholesterol level, and use of statin medications.
Outcomes:
CAC prevalence, severity, incidence, and progression.
Analytical Approach:
Multivariable-adjusted generalized linear models.
Results:
At baseline, 824 (65%) participants had prevalent CAC. After multivariable adjustment, T50 was not associated with CAC prevalence but was significantly associated with greater CAC severity among participants with prevalent CAC: 1-SD lower T50 was associated with 21% (95% CI, 6%-38%) greater CAC severity. Among 780 participants followed up an average of 3 years later, 65 (20%) without baseline CAC developed incident CAC, while 89 (19%) with baseline CAC had progression, defined as annual increase≥100 Agatston units. After multivariable adjustment, T50 was not associated with incident CAC but was significantly associated with CAC progression: 1-SD lower T50 was associated with 28% (95% CI, 7%-53%) higher risk for CAC progression.
Limitations:
Potential selection bias in follow-up analyses; inability to distinguish intimal from medial calcification.
Conclusions:
Among patients with CKD stages 2 to 4, higher serum calcification propensity is associated with more severe CAC and CAC progression.
More Related Videos
Related Concept Videos
Serum Studies: Renal Function Tests
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease V: Interprofessional Care
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Coronary Artery Disease IV: Preventive Measures

